Tandem Labs (now Covance) is a leading bioanalytical service provider with cutting-edge technology and services focused on supporting small and large-molecule development efforts for discovery, pre-clinical and clinical studies. We strive to differentiate ourselves with our scientific expertise, responsive project management staff, structured method development, on-time metrics, and strong regulatory history. Our goal is to use our experience to make your job easier and to shorten your development timelines. Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading health care diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. Going forward, Tandem Labs and Covance will operate together under the Covance brand. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue in excess of $8 billion in 2013 and more than 48,000 employees in over 60 countries, LabCorp offers innovative solutions to healthcare stakeholders. LabCorp clients include physicians, patients and consumers, biopharmaceutical companies, government agencies, managed care organizations, hospitals, and clinical labs. To learn more about Covance Drug Development, visit www.covance.com.